• Hypothyroidism in children (lecture for paediatricians and general practitioners)

Hypothyroidism in children (lecture for paediatricians and general practitioners)

SOVREMENNAYA PEDIATRIYA.2017.6(86):17-27; doi 10.15574/SP.2017.86.17

Mamenko M. Ye.
Shupyk National Medical Academy of Postgraduate Education, Kyiv, Ukraine

The functional depression of thyroid gland negatively affects the child's growth, physical, neuropsychic and mental development, metabolic activity and energy balance. Low-specific and subclinical course of hypothyroidism often leads to late diagnosis, which reduces the efficacy treatment. Special attention should be paid to the congenital and subclinical forms of acquired hypothyroidism in children as the most frequent manifestations of thyroid hypofunction. Awareness of the symptoms, methods of primary diagnosis and the possibilities of modern therapy by paediatricians and general practitioners is a prerequisite for the timely detection of hypothyroidism in paediatric population and its adequate correction.
Key words: hypothyroidism, children, diagnosis, treatment.


1. Zelinska NB. (2015). Vrodzhenyi hipotyreoz. Ukrainskyi zhurn dytiachoi endokrynol. 1: 67—68. http://nbuv.gov.ua/UJRN/ujde_2015_1_14.

2. Zelinska NB. (2015). Yuvenilnyi hipotyreoz. Ukrainskyi zhurnal dytiachoi endokrynolohii. 1: 69—70. http://nbuv.gov.ua/UJRN/ujde_2015_1_15.

3. Mamenko ME. (2013). Hypotyreoz u detei. Dytiachyi likar. 2: 32—39.

4. Protokol nadannia medychnoi dopomohy ditiam za spetsialnistiu «Dytiacha endokrynolohiia». Nakaz MOZ Ukrainy №254 vid 27.04.2006 r. (2006). Kyiv: 88.

5. Mathai S, Cutfield WS, Gunn AJ et al. (2008). A novel therapeutic paradigm to treat congenital hypothyroidism. Clin Endocrinol. 69: 142—147. https://doi.org/10.1111/j.1365-2265.2008.03172.x; PMid:18598275

6. Hennessey JV, Malabanan AO, Haugen BR, Levy EG. (2010). Adverse event reporting in patients treated with levothyroxine: results of the pharmacovigilance task force survey of the American Thyroid Association, American Association of Clinical Endocrinologists, and the Endocrine Society. Endocr Pract. 16: 357—370. https://doi.org/10.4158/EP0362.OR; PMid:20551006

7. Mechanick JI, Brett EM, Chausmer AB et al. (2003). American Association of Clinical Endocrinologists medical guidelines for the clinical use of dietary supplements and nutraceuticals. Endocr Pract. 9: 417—470. https://doi.org/10.4158/EP.9.5.417; PMid:14583426

8. Gharib H, Tuttle RM, Baskin HJ et al. American Association of Clinical Endocrinologists; American Thyroid Association; Endocrine Society 2005 Consensus Statement #1: Subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and The Endocrine Society. Thyroid. 15: 24—28; response 32—23.

9. Shakir KM, Turton D, Aprill BS et al. (2000). Anemia: a cause of intolerance to thyroxine sodium. Mayo Clin Proc. 75: 189—192. https://doi.org/10.4065/75.2.189; https://doi.org/10.1016/S0025-6196(11)64193-1

10. Angermayr L, Clar C. (2004). Iodine supplementation for preventing iodine deficiency disorders in children. Cochrane Database of Systematic Reviews, Issue 2. Art. No.: CD003819. https://doi.org/10.1002/14651858.CD003819.pub2; PMid:15106221

11. Virilic J, Bassotti G, Santaguida MG et al. (2012). Atypical celiac disease as cause of increased need for thyroxine: a systematic study. J Clin Endocrinol Metab. 97: 419—422. https://doi.org/10.1210/jc.2011-1851; PMid:22238404

12. Balhara B, Misra M, Levitsky LL. (2011). Clinical monitoring guidelines for congenital hypothyroidism: laboratory outcome data in the first year of life. J Pediatr. 158: 532—537. https://doi.org/10.1016/j.jpeds.2010.10.006; PMid:21094953

13. Beck-Peccoz P. (2011). Treatment of central hypothyroidism. Clin Endocrinol. 74: 671—672. https://doi.org/10.1111/j.1365-2265.2011.04037.x; PMid:21521306

14. Biondi B, Cooper DS. (2008). The clinical significance of subclinical thyroid dysfunction. Endocr Rev. 29: 76—131. https://doi.org/10.1210/er.2006-0043; PMid:17991805

15. Biondi B, Wartofsky L. (2014). Treatment with thyroid hormone. Endocr Rev. 35: 433—512. https://doi.org/10.1210/er.2013-1083; PMid:24433025

16. Brent GA. (2012). Mechanisms of thyroid hormone action. J Clin Invest. 122: 3035—3043. https://doi.org/10.1172/JCI60047; PMid:22945636 PMCid:PMC3433956

17. Brown RS. (2009). Chapter 15b — Disorders of the Thyroid Gland in Infancy, Childhood and Adolescence. URL: http://www.thyroidmanager.org.

18. De Vries L, Bulvik S, Phillip M. Chronic autoimmune thyroiditis in children and adolescents: at presentation and during long-term follow-up. Arch Dis Child. 94: 33—37. https://doi.org/10.1136/adc.2007.134841; PMid:18703546

19. Visser WE, van Mullem AA, Visser TJ, Peeters RP. (2013). Different causes of reduced sensitivity to thyroid hormone: diagnosis and clinical management. Clin Endocrinol. 79: 595—605. https://doi.org/10.1111/cen.12281

20. Nebesio TD, Wise MD, Perkins SM, Eugster EA. (2011). Does clinical management impact height potential in children with severe acquired hypothyroidism? J Pediatr Endocrinol Metab. 24: 893—896. https://doi.org/10.1515/JPEM.2011.310; PMid:22308838

21. Choi YH, Choi WY, Kang HC et al. (2012). Drug rash induced by levothyroxine tablets. Thyroid. 22: 1090. https://doi.org/10.1089/thy.2011.0462; PMid:22962862

22. Eisenberg M, Distefano JJ. (2009). TSH-based protocol, tablet instability, and absorption effects on LT4 bioequivalence. Thyroid. 19: 103—110. https://doi.org/10.1089/thy.2008.0148; PMid:19191742 PMCid:PMC2858298

23. Monzani A, Prodam F, Rapa A et al. (2013). Endocrine disorders in childhood and adolescence. Natural history of subclinical hypothyroidism in children and adolescents and potential effects of replacement therapy: a review. Eur J Endocrinol. 168: R1—R11. https://doi.org/10.1530/EJE-12-0656; PMid:22989466

24. Leger J, Olivieri A, Donaldson M et al. (2014). European Society for Paediatric Endocrinology consensus guidelines on screening, diagnosis, and management of congenital hypothyroidism. ESPE-PES-SLEP-JSPE-APEG-APPES-ISPAE; Congenital Hypothyroidism Consensus Conference Group. J Clin Endocrinol Metab. 99: 363—384. https://doi.org/10.1210/jc.2013-1891; PMid:24446653 PMCid:PMC4207909

25. Lazarus J, Brown RS, Daumerie C et al. (2014). European Thyroid Association Guidelines for the Management of Subclinical Hypothyroidism in Pregnancy and in Children.

26. Carswell JM, Gordon JH, Popovsky E et al. (2013). Generic and brand-name L-thyroxine are not bioequivalent for children with severe congenital hypothyroidism. J Clin Endocrinol Metab. 98: 610—617. https://doi.org/10.1210/jc.2012-3125; PMid:23264396 PMCid:PMC3565118

27. Lomenick JP, Wang L, Ampah SB et al. (2013). Generic levothyroxine compared with synthroid in young children with congenital hypothyroidism. J Clin Endocrinol Metab. 98: 653-658. https://doi.org/10.1210/jc.2012-3558; PMid:23293325

28. Taylor PN, Okosieme OE, Dayan CM, Lazarus JH. (2014). Impact of iodine supplementation in mild-to-moderate iodine deficiency: systematic review and meta-analysis. Eur J Endocrinol. 170(1): 1—15. https://doi.org/10.1530/EJE-13-0651; PMid:24088547

29. John-Kalarickal J, Pearlman G, Carlson HE. (2007). New medications which decrease levothyroxine absorption. Thyroid. 17: 763—765. https://doi.org/10.1089/thy.2007.0060; PMid:17725434

30. Kaplowitz PB. (2010). Subclinical hypothyroidism in children: normal variation or sign of a failing thyroid gland? Int J Pediatr Endocrinol: 281453. https://doi.org/10.1186/1687-9856-2010-281453; PMid:20628588 PMCid:PMC2901603

31. Kaptein EM, Beale E, Chan LS. (2009). Thyroid hormone therapy for obesity and nonthyroidal illnesses: a systematic review. J Clin Endocrinol Metab. 94: 3663—3675. https://doi.org/10.1210/jc.2009-0899; PMid:19737920

32. Kundra P, Burman KD. (2012). The effect of medications on thyroid function tests. Med Clin North Am. 96: 283—295. https://doi.org/10.1016/j.mcna.2012.02.001; PMid:22443976

33. La Franchi SH, Austin J. (2007). How should we be treating children with congenital hypothyroidism? J Pediatr Endocrinol Metab. 20: 559—578.

34. Lania A, Persani L, Beck-Peccoz P. (2008). Central hypothyroidism. Pituitary. 11: 181—186. https://doi.org/10.1007/s11102-008-0122-6; PMid:18415684

35. Devdhar M, Drooger R, Pehlivanova M et al. (2011). Levothyroxine replacement doses are affected by gender and weight, but not age. Thyroid. 21: 821—827. https://doi.org/10.1089/thy.2011.0029; PMid:21751885 PMCid:PMC3148125

36. Razvi S, Weaver JU, Butler TJ, Pearce SH. (2012). Levothyroxine treatment of subclinical hypothyroidism, fatal and nonfatal cardiovascular events, and mortality. Arch Intern Med. 172: 811—817. https://doi.org/10.1001/archinternmed.2012.1159; PMid:22529180

37. Cerbone M, Bravaccio C, Capalbo D et al. (2011). Linear growth and intellectual outcome in children with long-term idiopathic subclinical hypothyroidism. Eur J Endocrinol. 164: 591—597. https://doi.org/10.1530/EJE-10-0979; PMid:21292920

38. Lomenick JP, El-Sayyid M, Smith WJ. (2008). Effect of levo-thyroxine treatment on weight and body mass index in children with acquired hypothyroidism. J Pediatr. 152: 96—100. https://doi.org/10.1016/j.jpeds.2007.06.006; PMid:18154908

39. Magen E, Mishal J. (2012). The effect of L-thyroxine treatment on chronic idiopathic urticaria and autoimmune thyroiditis. Int J Dermatol. 51: 94—97. https://doi.org/10.1111/j.1365-4632.2011.05172.x; PMid:22182385

40. Munoz-Torres M, Varsavsky M, Alonso G. (2006). Lactose intolerance revealed by severe resistance to treatment with levothyroxine. Thyroid. 16: 1171—1173. https://doi.org/10.1089/thy.2006.16.1171; PMid:17123345

41. Lazar L, Frumkin RB, Battat E et al. (2009). Natural history of thyroid function tests over 5 years in a large pediatric cohort. J Clin Endocrinol Metab. 94: 1678—1682. https://doi.org/10.1210/jc.2008-2615; PMid:19240148

42. O'Grady MJ, Cody D. (2011). Subclinical hypothyroidism in childhood. Arch Dis Child. 96: 280—284. https://doi.org/10.1136/adc.2009.181800; PMid:20413616

43. Raine Joseph E, Malcolm DC Donaldson, John W Gregory, Guy Van Vilet. (2010). Practical Endocrinology and Diabetes in Children. 3-thd edition. Wiley-Blackwell: 258.

44. Practical Paediatric Endocrinology in a Limited Resource Setting. Editor M Zacharin. (2011). Melburne, Australia: 320.

45. Rajput R, Chatterjee S, Rajput M. (2011). Can levothyroxine be taken as evening dose? Comparative evaluation of morning versus evening dose of levothyroxine in treatment of hypothyroidism. J Thyroid Res: 505239. https://doi.org/10.4061/2011/505239

46. Refetoff S, Dumitrescu AM. (2007). Syndromes of reduced sensitivity to thyroid hormone: genetic defects in hormone receptors, cell transporters and deiodination. Best Pract Res Clin Endocrinol Metab. 21: 277—305. https://doi.org/10.1016/j.beem.2007.03.005; PMid:17574009

47. Ittermann T, Thamm M, Wallaschofski H et al. (2012). Serum thyroid-stimulating hormone levels are associated with blood pressure in children and adolescents. J Clin Endocrinol Metab. 97: 828—834. https://doi.org/10.1210/jc.2011-2768; PMid:22205713

48. Perez L, Araki FS, Graf H, de Carvalho GA. (2013). Serum thyrotropin levels following levothyroxine administration at breakfast. Thyroid. 23: 779—784. https://doi.org/10.1089/thy.2012.0435; PMid:23363386

49. Hollowell JG, Staehling NW, Flanders WD et al. (2002). Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 87: 489—499. https://doi.org/10.1210/jcem.87.2.8182; PMid:11836274

50. Surks MI, Goswami G, Daniels GH. (2005). The thyrotropin reference range should remain unchanged. J Clin Endocrinol Metab. 90: 5489—5496. https://doi.org/10.1210/jc.2005-0170; PMid:16148346

51. Bugdaci MC, Zuhur SS, Sokmen M et al. (2011). The role of Helicobacter pylori in patients with hypothyroidism in whom could not be achieved normal thyrotropin levels despite treatment with high doses of thyroxine. Helicobacter. 16: 124—130. https://doi.org/10.1111/j.1523-5378.2011.00830.x; PMid:21435090

52. Pacifico L, Anania C, Ferraro F et al. (2012). Thyroid function in childhood obesity and metabolic comorbidity. Clin Chim Acta. 413: 396—405. https://doi.org/10.1016/j.cca.2011.11.013; PMid:22130312

53. Almeida OP, Alfonso H, Flicker L et al. (2011). Thyroid hormones and depression: the Health in Men study. Am J Geriatr Psychiatry. 19: 763—770. https://doi.org/10.1097/JGP.0b013e31820dcad5; PMid:21873831

54. U.S. Food and Drug Administration. Questions and answers on levothyroxine sodium products. URL: http://www.fda.gov/Drugs/DrugSafety/Postmarket Drug Safety Information for Patients and Providers/ucm161266.htm

55. Bagnasco M, Minciullo PL, Saraceno GS et al. (2011). Urticaria and thyroid autoimmunity. Thyroid. 21: 401—410. https://doi.org/10.1089/thy.2010.0103; PMid:21323598

56. Van den Berghe G. (2014). Non-thyroidal illness in the ICU: a syndrome with different faces. Thyroid. 24: 1456—1465. https://doi.org/10.1089/thy.2014.0201; PMid:24845024 PMCid:PMC4195234

57. Vita R, Benvenga S. (2014). Tablet levothyroxine (L-T4) malabsorption induced by proton pump inhibitor; a problem that was solved by switching to L-T4 in soft gel capsule. Endocr Pract. 20(3): 38—41. https://doi.org/10.4158/EP13316.CR; PMid:24246350

58. Zamfirescu I, Carlson HE. (2011). Absorption of levothyroxine when coadministered with various calcium formulations. Thyroid. 21: 483—486. https://doi.org/10.1089/thy.2010.0296; PMid:21595516 PMCid:PMC3092723

59. Zimmermann MB. (2009). Iodine Deficiency. Endocrine Reviews. 30(4): 376—408. https://doi.org/10.1210/er.2009-0011; PMid:19460960

60. Zimmermann MB, Jooste PL, Pandav CS. (2008). Iodine-deficiency disorders. Lancet. 372(9645): 1251—1262. https://doi.org/10.1016/S0140-6736(08)61005-3